Literature DB >> 2141579

Isotretinoin and acne--a study of relapses.

M Chivot1, H Midoun.   

Abstract

A study was carried out involving 172 patients with acne which warranted treatment with isotretinoin. Patients were followed up for between 12 and 41 months after discontinuation of treatment and the number of relapses was assessed. 37 patients (21%) relapsed. These relapses were correlated with patients' age, length of disease progression prior to treatment, total dose received, daily dose, duration of treatment and severity of acne. It appeared that only young age and severity of acne influenced the percentage of relapse.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2141579     DOI： 10.1159/000248038

Source DB:  PubMed          Journal:  Dermatologica        ISSN： 0011-9075


  5 in total

Review 1.  Guidelines for the management of acne vulgaris in adolescents.

Authors:  Victoria Goulden
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 2.  Not all acne is acne vulgaris.

Authors:  Harald P Gollnick; Christos C Zouboulis
Journal:  Dtsch Arztebl Int       Date:  2014-04-25       Impact factor: 5.594

Review 3.  A review of diagnosis and treatment of acne in adult female patients.

Authors:  A U Tan; B J Schlosser; A S Paller
Journal:  Int J Womens Dermatol       Date:  2017-12-23

4.  Double-blinded, vehicle-controlled proof of concept study to investigate the recurrence of inflammatory and noninflammatory acne lesions using tretinoin gel (microsphere) 0.04% in male patients after oral isotretinoin use.

Authors:  Reid Vender; Ronald Vender
Journal:  Dermatol Res Pract       Date:  2012-04-19

5.  Efficacy of fixed daily 20 mg of isotretinoin in moderate to severe scar prone acne.

Authors:  Abbas Rasi; Elham Behrangi; Masoumeh Rohaninasab; Zahra Mehr Nahad
Journal:  Adv Biomed Res       Date:  2014-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.